For people who experience severe muscle and joint pain from statin medications, Repatha offers a viable alternative that can effectively lower cholesterol without the debilitating side effects. This injectable drug belongs to a class called PCSK9 inhibitors, which work differently than traditional statins and may be worth discussing with your doctor if you've struggled with statin tolerance.

What Makes Repatha Different From Statins?

Repatha is in the class of drugs called PCSK9 inhibitors, which were first approved in 2015. Unlike statins, which work by blocking cholesterol production in the liver, PCSK9 inhibitors take a different approach to lowering cholesterol levels. These medications are very effective at reducing cholesterol, particularly for people who already have diagnosed heart disease.

The key difference lies in tolerability. Many patients report experiencing significant muscle aches and joint pain when taking statins, sometimes severe enough that they stop the medication entirely. Repatha, administered as a self-injection every other week, has shown no such side effects in patients who've tried it, making it an attractive option for those who've had negative experiences with traditional cholesterol medications.

How Effective Is Repatha at Reducing Heart Disease Risk?

Most evidence supporting PCSK9 inhibitors comes from studies in people who already have diagnosed heart disease. In this high-risk group, these drugs reduced the relative risk of having a heart attack, stroke, or dying from vascular disease by about 15 percent. While this sounds promising, it's important to understand what this means in practical terms: roughly 2 people out of 100 would avoid a serious cardiovascular event when taking the medicine, compared to people who didn't take it.

The absolute benefit is smaller than the relative risk reduction suggests. For every 50 people who need to be treated with a PCSK9 inhibitor to prevent one bad outcome over three years, the medication works as intended. This is still meaningful for people at high risk, but it's not a guaranteed prevention strategy.

Who Should Consider Repatha as an Alternative?

No studies have specifically tested PCSK9 inhibitors in people at low risk for heart disease, so the evidence base for using these drugs in that population is limited. However, one recent study examined people who didn't have known blockages in their blood vessels but did have diabetes, and it showed similar benefits to what's seen in higher-risk groups.

For women, the picture is somewhat different. While statins are as effective at reducing a woman's relative risk for heart disease as they are for men, women overall face a lower absolute risk than men of the same age. This means that more women would need to be treated with a statin to prevent one bad outcome compared to men, making the decision to start medication more nuanced.

How to Decide Between Statins and Repatha

• Statin Tolerance: If you've experienced severe muscle aches, joint pain, or other side effects from statins that made you stop taking them, Repatha may be worth discussing with your doctor as an alternative cholesterol-lowering option.
• Risk Level Assessment: The exact level of risk you're willing to tolerate against the tolerance of a new medication is key in every patient, in whom medication treatment is considered to lower heart disease and stroke risk.
• Lifestyle Modifications First: Many patients have improved their blood pressure and cholesterol levels so much through their diet and exercise regimen that they no longer needed medication recommendations from their doctor.

Statins have a much larger evidence base supporting their use than PCSK9 inhibitors when it comes to preventing disease in higher-risk people without known blockages, as well as those who already have blockages. A review of 50,000 women who were studied in trials showed that statins are as effective at reducing a woman's relative risk for heart disease as they are with a man's. But the issue of women having a lower absolute risk means that just as with PCSK9 inhibitors, more women need to be treated with a statin to prevent a bad outcome than men of a similar age.

"There are no head-to-head trials comparing PCSK9 inhibitors against statins, so I cannot definitively give an answer as to which is better. In my own practice, I continue to use statins as the first-line treatment in both men and women who are at an increased risk for heart disease," a medical expert stated.

Dr. Roach, Physician

If statins aren't tolerated, it is worth considering alternative medications, including ezetimibe, bempedoic acid and PCSK9 inhibitors. It's very likely that the first oral PCSK9 inhibitor will be approved soon, which could make this class of medication more accessible to patients who prefer pills over injections.

The bottom line is that cholesterol management isn't one-size-fits-all. Your doctor should work with you to find a medication strategy that you can actually stick with long-term, because the best medication is one you'll actually take consistently. If statins cause unacceptable side effects, discussing alternatives like Repatha with your healthcare provider is a reasonable next step in protecting your cardiovascular health.